paradromics.comHealthcare / Digital HealthFounded: 2015Funding to Date: $66.81MM
Paradromics, Inc. is a biotechnology company that develops advanced neural interfaces to enable high-bandwidth connections between brains and computers. The company's platform offers a range of features and tools for developing and commercializing next-generation neural interfaces that can help restore communication and movement for people with paralysis, brain injury, and other neurological disorders.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/18/2023 | Series A-3 | $32.15MM | $xx.xx | $408.67MM | Dolby Family Ventures, Green Sands Equity, Prime Movers Lab, Wescott Investment Group | |
Price per Share
$xx.xx
Shares Outstanding
27,377,078
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Dolby Family Ventures, Green Sands Equity, Prime Movers Lab, Wescott Investment Group
|
||||||
07/22/2021 | Series A-1 | $25.1MM | $xx.xx | $123.48MM | Alpha Edison, Dolby Family Ventures, It-Farm, Prime Movers Lab, Pureland Global Venture, Synergy Ventures, Wescott Investment Group | |
Price per Share
$xx.xx
Shares Outstanding
74,020,236
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alpha Edison, Dolby Family Ventures, It-Farm, Prime Movers Lab, Pureland Global Venture, Synergy Ventures, Wescott Investment Group
|
||||||
01/15/2021 | Series A-2 | $9.55MM | $xx.xx | $47.77MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
35,218,291
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|